Pharmaceutical compositions
US5593665A · kind A · utility
28Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 1994 |
| Grant date | Jan 14, 1997 |
| Priority date | — |
| Expiry date | May 17, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides products containing tumour necrosis factor (TNF), and taurolidine and/or taurultam as a combined preparation for simultaneous, separate or sequential use for treatment of patients suffering from medical conditions mediated by TNF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.